You are currently on the new version of our website. Access the old version .

104 Results Found

  • Article
  • Open Access
4 Citations
4,560 Views
12 Pages

Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models

  • Maria Lambouras,
  • Charlotte Roelofs,
  • Melrine Pereira,
  • Emily Gruber,
  • Jessica L. Vieusseux,
  • Patrick Lanteri,
  • Cameron N. Johnstone,
  • Fenella Muntz,
  • Sandra O’Toole and
  • Kara L. Britt
  • + 2 authors

Estrogen receptor-positive breast cancers (ER+ BCas) are the most common form of BCa and are increasing in incidence, largely due to changes in reproductive practices in recent decades. Tamoxifen is prescribed as a component of standard-of-care endoc...

  • Article
  • Open Access
19 Citations
5,337 Views
22 Pages

ERK Activation Modulates Cancer Stemness and Motility of a Novel Mouse Oral Squamous Cell Carcinoma Cell Line

  • Yu-Lin Chen,
  • Ko-Jiunn Liu,
  • Chuan-Wei Jang,
  • Chia-Chun Hsu,
  • Yi-Chen Yen,
  • Yi-Ling Liu,
  • Tsung-Hsien Chuang,
  • Ssu-Han Wang,
  • Yu-Ke Fu and
  • Ya-Wen Chen

24 December 2019

We established the NHRI-HN1 cell line from a mouse tongue tumor induced by 4-nitroquinoline 1-oxide (4-NQO)/arecoline, with further selection for cell stemness via in vitro sphere culture, to evaluate potential immunotherapies for oral squamous cell...

  • Article
  • Open Access
5 Citations
4,125 Views
13 Pages

18 October 2023

There is a clear need to expand the toolkit of adequate mouse models and cell lines available for preclinical studies of high-grade neuroendocrine lung carcinoma (small cell lung carcinoma (SCLC) and large cell neuroendocrine carcinoma (LCNEC)). SCLC...

  • Article
  • Open Access
19 Citations
8,022 Views
20 Pages

A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors

  • Barbara Costa,
  • Michael N. C. Fletcher,
  • Pavle Boskovic,
  • Ekaterina L. Ivanova,
  • Tanja Eisemann,
  • Sabrina Lohr,
  • Lukas Bunse,
  • Martin Löwer,
  • Stefanie Burchard and
  • Heike Peterziel
  • + 7 authors

10 January 2021

Glioblastomas (GBM) are the most aggressive tumors affecting the central nervous system in adults, causing death within, on average, 15 months after diagnosis. Immunocompetent in-vivo models that closely mirror human GBM are urgently needed for decip...

  • Article
  • Open Access
4 Citations
2,780 Views
17 Pages

Generation of a Syngeneic Heterozygous ACVRL1(wt/mut) Knockout iPS Cell Line for the In Vitro Study of HHT2-Associated Angiogenesis

  • Li Xiang-Tischhauser,
  • Michael Bette,
  • Johanna R. Rusche,
  • Katrin Roth,
  • Norio Kasahara,
  • Boris A. Stuck,
  • Udo Bakowsky,
  • Maria Wartenberg,
  • Heinrich Sauer and
  • Robert Mandic

10 June 2023

Hereditary hemorrhagic telangiectasia (HHT) type 2 is an autosomal dominant disease in which one allele of the ACVRL1 gene is mutated. Patients exhibit disturbances in TGF-beta/BMP-dependent angiogenesis and, clinically, often present with severe nos...

  • Review
  • Open Access
8 Citations
6,192 Views
15 Pages

Translational Models in Glioma Immunotherapy Research

  • Alexander L. Ren,
  • Janet Y. Wu,
  • Si Yeon Lee and
  • Michael Lim

11 June 2023

Immunotherapy is a promising therapeutic domain for the treatment of gliomas. However, clinical trials of various immunotherapeutic modalities have not yielded significant improvements in patient survival. Preclinical models for glioma research shoul...

  • Article
  • Open Access
18 Citations
4,142 Views
15 Pages

Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments

  • Sung-Won Shin,
  • Kyungmi Yang,
  • Miso Lee,
  • Jiyoung Moon,
  • Arang Son,
  • Yeeun Kim,
  • Suha Choi,
  • Do-hyung Kim,
  • Changhoon Choi and
  • Hee Chul Park

We evaluated the effect of manganese ferrite nanoparticles (MFN) on radiosensitization and immunologic responses using the murine hepatoma cell line Hepa1-6 and the syngeneic mouse model. The clonogenic survival of Hepa1-6 cells was increased by hypo...

  • Article
  • Open Access
8 Citations
4,247 Views
12 Pages

31 March 2020

Background: Several lines of evidence have demonstrated the tumor-promoting function of inflammation. Since many chemokines are important in coordinating immune cells during inflammation, monitoring intratumoral chemokines provides a way to study the...

  • Article
  • Open Access
2 Citations
3,070 Views
15 Pages

Molecular Mechanisms in Murine Syngeneic Leukemia Stem Cells

  • Michael Chamo,
  • Omri Koren,
  • Oron Goldstein,
  • Nir Bujanover,
  • Nurit Keinan,
  • Ye’ela Scharff and
  • Roi Gazit

24 January 2023

Acute Myeloid Leukemia (AML) is a severe disease with a very high relapse rate. AML relapse may be attributable to leukemic stem cells (LSC). Notably, the “cancer stem cell” theory, which relates to LSCs, is controversial and criticized d...

  • Article
  • Open Access
2,783 Views
14 Pages

Development and Characterization of Syngeneic Orthotopic Transplant Models of Obesity-Responsive Triple-Negative Breast Cancer in C57BL/6J Mice

  • Meredith S. Carson,
  • Patrick D. Rädler,
  • Jody Albright,
  • Melissa VerHague,
  • Erika T. Rezeli,
  • Daniel Roth,
  • John E. French,
  • Charles M. Perou,
  • Stephen D. Hursting and
  • Michael F. Coleman

9 August 2024

Obesity is an established risk and progression factor for triple-negative breast cancer (TNBC), but preclinical studies to delineate the mechanisms underlying the obesity-TNBC link as well as strategies to break that link are constrained by the lack...

  • Article
  • Open Access
854 Views
17 Pages

Murine Cell Line Models for Vascular Mimicry: The Role of YAP/TAZ Signaling

  • Matilde Righetti,
  • Ana-Maria Primorac,
  • Janine Terra Erler and
  • Victor Oginga Oria

18 September 2025

Vascular mimicry (VM) refers to the formation of vessel-like structures by tumor cells independent of endothelial cells. These VM channels connect to the host’s vascular network and are associated with aggressive tumors and poor patient prognos...

  • Article
  • Open Access
20 Citations
5,368 Views
17 Pages

Marine Seagrass Extract of Thalassia testudinum Suppresses Colorectal Tumor Growth, Motility and Angiogenesis by Autophagic Stress and Immunogenic Cell Death Pathways

  • Ivones Hernández-Balmaseda,
  • Idania Rodeiro Guerra,
  • Ken Declerck,
  • José Alfredo Herrera Isidrón,
  • Claudina Pérez-Novo,
  • Guy Van Camp,
  • Olivier De Wever,
  • Kethia González,
  • Mayrel Labrada and
  • Wim Vanden Berghe
  • + 7 authors

22 January 2021

Marine plants have become an inexhaustible reservoir of new phytopharmaceuticals for cancer treatment. We demonstrate in vitro/in vivo antitumor efficacy of a standardized polyphenol extract from the marine angiosperm Thalassia testudinum (TTE) in co...

  • Article
  • Open Access
15 Citations
5,695 Views
17 Pages

Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib

  • Sami Znati,
  • Rebecca Carter,
  • Marcos Vasquez,
  • Adam Westhorpe,
  • Hassan Shahbakhti,
  • Jessica Prince,
  • Petra Vlckova,
  • Chiara De Vellis,
  • Zainab Bascal and
  • Ricky A. Sharma

13 July 2020

Hepatocellular Carcinoma (HCC) is increasing in incidence worldwide and requires new approaches to therapy. The combination of anti-angiogenic drug therapy and radiotherapy is one promising new approach. The anti-angiogenic drug vandetanib is a tyros...

  • Article
  • Open Access
1,326 Views
18 Pages

Dauricine Impedes the Tumorigenesis of Lung Adenocarcinoma by Regulating Nrf2 and Reactive Oxygen Species

  • Waleed Yousuf,
  • Nimra Zafar Siddiqui,
  • Perbhat Ali,
  • Shaoxuan Cheng,
  • Immad Ansari,
  • Jialiang Song,
  • Minghe Dai,
  • Zhiyuan Qiu,
  • Yue Zhu and
  • Han Liu
  • + 3 authors

12 May 2025

Dauricine has been shown to possess intriguing anti-cancerous activities against various malignancies. The current study examined the inhibitory effects of dauricine against lung adenocarcinoma with cell lines and animal models. MTT assay was perform...

  • Article
  • Open Access
20 Citations
4,660 Views
27 Pages

Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo

  • Yanrong Qian,
  • Reetobrata Basu,
  • Samuel C. Mathes,
  • Nathan A. Arnett,
  • Silvana Duran-Ortiz,
  • Kevin R. Funk,
  • Alison L. Brittain,
  • Prateek Kulkarni,
  • Joseph C. Terry and
  • John J. Kopchick
  • + 4 authors

4 December 2020

Growth hormone (GH) and the GH receptor (GHR) are expressed in a wide range of malignant tumors including melanoma. However, the effect of GH/insulin-like growth factor (IGF) on melanoma in vivo has not yet been elucidated. Here we assessed the physi...

  • Article
  • Open Access
64 Citations
8,672 Views
16 Pages

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma

  • Janine Kimpel,
  • Carles Urbiola,
  • Iris Koske,
  • Reinhard Tober,
  • Zoltan Banki,
  • Guido Wollmann and
  • Dorothee Von Laer

2 March 2018

Previously, we described VSV-GP, a modified version of the vesicular stomatitis virus, as a non-neurotoxic oncolytic virus that is effective for the treatment of malignant glioblastoma and ovarian cancer. Here, we evaluate the therapeutic efficacy of...

  • Article
  • Open Access
5 Citations
5,001 Views
10 Pages

In Vitro Priming of Human T Cells by Dendritic Cells Provides a Screening Tool for Candidate Vaccines for Burkholderia pseudomallei

  • Durga Reddi,
  • Lydia Durant,
  • David Bernardo,
  • Alistair Noble,
  • Nicholas R. English,
  • Philip Hendy,
  • Graeme C. Clark,
  • Joann L. Prior,
  • Ethel Diane Williamson and
  • Stella C. Knight

22 August 2021

Murine dendritic cells, when pulsed with heat-killed Burkholderia pseudomallei and used to immunise naïve mice, have previously been shown to induce protective immunity in vivo. We have now demonstrated the in vitro priming of naïve human T cells aga...

  • Article
  • Open Access
11 Citations
3,379 Views
18 Pages

Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H

  • Ahmet Hazini,
  • Babette Dieringer,
  • Karin Klingel,
  • Markian Pryshliak,
  • Anja Geisler,
  • Dennis Kobelt,
  • Ole Daberkow,
  • Jens Kurreck,
  • Sophie van Linthout and
  • Henry Fechner

24 September 2021

The coxsackievirus B3 strain PD-0 has been proposed as a new oncolytic virus for the treatment of colorectal carcinoma. Here, we generated a cDNA clone of PD-0 and analyzed the virus PD-H, newly generated from this cDNA, in xenografted and syngenic m...

  • Article
  • Open Access
3 Citations
3,492 Views
14 Pages

Spatio-Temporal Bone Remodeling after Hematopoietic Stem Cell Transplantation

  • Constanze S. Schwarz,
  • Christian H. Bucher,
  • Claudia Schlundt,
  • Sarah Mertlitz,
  • Katarina Riesner,
  • Martina Kalupa,
  • Lydia Verlaat,
  • Oskar Schmidt-Bleek,
  • Radost A. Sass and
  • Il-Kang Na
  • + 2 authors

29 December 2020

The interaction of hematopoietic cells and the bone microenvironment to maintain bone homeostasis is increasingly appreciated. We hypothesized that the transfer of allogeneic T lymphocytes has extensive effects on bone biology and investigated trabec...

  • Article
  • Open Access
13 Citations
3,232 Views
14 Pages

Anticancer Effect of Cold Atmospheric Plasma in Syngeneic Mouse Models of Melanoma and Colon Cancer

  • Joon-Min Jung,
  • Hae-Kyeong Yoon,
  • Su-Yeon Kim,
  • Mi-Ra Yun,
  • Gyeong-Hoon Kim,
  • Woo-Jin Lee,
  • Mi-Woo Lee,
  • Sung-Eun Chang and
  • Chong-Hyun Won

Cold atmospheric plasma (CAP) may have applications in treating various types of malignant tumors. This study assessed the anticancer effects of CAP using melanoma and colon cancer cell lines. CAP treatment significantly reduced the in vitro viabilit...

  • Article
  • Open Access
10 Citations
6,874 Views
20 Pages

Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer

  • Charles M. Haughey,
  • Debayan Mukherjee,
  • Rebecca E. Steele,
  • Amy Popple,
  • Lara Dura-Perez,
  • Adam Pickard,
  • Mehjabin Patel,
  • Suneil Jain,
  • Paul B. Mullan and
  • Sharon L. Eddie
  • + 6 authors

29 September 2020

The prostate cancer (PCa) field lacks clinically relevant, syngeneic mouse models which retain the tumour microenvironment observed in PCa patients. This study establishes a cell line from prostate tumour tissue derived from the Pten−/−/t...

  • Article
  • Open Access
18 Citations
5,092 Views
24 Pages

Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers

  • Laurie Freire Boullosa,
  • Jinthe Van Loenhout,
  • Tal Flieswasser,
  • Christophe Hermans,
  • Céline Merlin,
  • Ho Wa Lau,
  • Elly Marcq,
  • Marlies Verschuuren,
  • Winnok H. De Vos and
  • Christophe Deben
  • + 1 author

Auranofin (AF) is a potent, off-patent thioredoxin reductase (TrxR) inhibitor that efficiently targets cancer via reactive oxygen species (ROS)- and DNA damage-mediated cell death. The goal of this study is to enhance the efficacy of AF as a cancer t...

  • Article
  • Open Access
14 Citations
6,002 Views
22 Pages

Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells

  • Iosune Baraibar,
  • Marta Roman,
  • María Rodríguez-Remírez,
  • Inés López,
  • Anna Vilalta,
  • Elisabeth Guruceaga,
  • Margarita Ecay,
  • María Collantes,
  • Teresa Lozano and
  • Ignacio Gil-Bazo
  • + 15 authors

28 October 2020

The use of PD-1/PD-L1 checkpoint inhibitors in advanced NSCLC is associated with longer survival. However, many patients do not benefit from PD-1/PD-L1 blockade, largely because of immunosuppression. New immunotherapy-based combinations are under inv...

  • Article
  • Open Access
1,166 Views
15 Pages

Epigenetic Treatment Alters Immune-Related Gene Signatures to Increase the Sensitivity of Anti PD-L1 Drugs

  • Chonji Fukumoto,
  • Pritam Sadhukhan,
  • Masahiro Shibata,
  • Muhammed T. Ugurlu,
  • Rachel Goldberg,
  • David Sidransky,
  • Luigi Marchionni,
  • Fenna C. M. Sillé and
  • Mohammad Obaidul Hoque

23 July 2025

Background/Objectives: Head and neck squamous cell carcinoma (HNSCC) is the seventh most prevalent cancer worldwide. Despite intensive treatments, the prognosis is unfavorable. Recently, immunotherapy has emerged as a novel therapeutic strategy, and...

  • Article
  • Open Access
13 Citations
4,217 Views
25 Pages

Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC)

  • Jessica L. S. Zylla,
  • Mariah M. Hoffman,
  • Simona Plesselova,
  • Somshuvra Bhattacharya,
  • Kristin Calar,
  • Yohannes Afeworki,
  • Pilar de la Puente,
  • Etienne Z. Gnimpieba,
  • W. Keith Miskimins and
  • Shanta M. Messerli

30 March 2022

This study investigates the effects of a dual selective Class I histone deacetylase (HDAC)/lysine-specific histone demethylase 1A (LSD1) inhibitor known as 4SC-202 (Domatinostat) on tumor growth and metastasis in a highly metastatic murine model of T...

  • Article
  • Open Access
15 Citations
3,866 Views
13 Pages

Background: Inflammation is known to promote tumor formation and progression; however, we found a natural anti-inflammatory factor, interleukin (IL)-1 receptor antagonist (IL1RN), in a mouse transgenic adenocarcinoma of the mouse prostate (TRAMP)-C1-...

  • Article
  • Open Access
15 Citations
3,607 Views
15 Pages

Late-Stage Glioma Is Associated with Deleterious Alteration of Gut Bacterial Metabolites in Mice

  • Aglae Herbreteau,
  • Philippe Aubert,
  • Mikaël Croyal,
  • Philippe Naveilhan,
  • Stéphanie Billon-Crossouard,
  • Michel Neunlist,
  • Yves Delneste,
  • Dominique Couez and
  • Laetitia Aymeric

25 March 2022

Brain-gut axis refers to the bidirectional functional connection between the brain and the gut, which sustains vital functions for vertebrates. This connection also underlies the gastrointestinal (GI) comorbidities associated with brain disorders. Us...

  • Article
  • Open Access
80 Citations
7,959 Views
15 Pages

Extraction, Chemical Composition, and Anticancer Potential of Origanum onites L. Essential Oil

  • Katerina Spyridopoulou,
  • Eleni Fitsiou,
  • Eleni Bouloukosta,
  • Angeliki Tiptiri-Kourpeti,
  • Manolis Vamvakias,
  • Antigoni Oreopoulou,
  • Eleni Papavassilopoulou,
  • Aglaia Pappa and
  • Katerina Chlichlia

18 July 2019

Origanum species are plants rich in volatile oils that are mainly used for culinary purposes. In recent years, there has been a growing interest in the biological activities of their essential oils. Origanum onites L. is a plant mainly found in Greec...

  • Article
  • Open Access
32 Citations
4,605 Views
19 Pages

Direct Transfer of Mesoporous Silica Nanoparticles between Macrophages and Cancer Cells

  • Stefan Franco,
  • Achraf Noureddine,
  • Jimin Guo,
  • Jane Keth,
  • Michael L. Paffett,
  • C. Jeffrey Brinker and
  • Rita E. Serda

9 October 2020

Macrophages line the walls of microvasculature, extending processes into the blood flow to capture foreign invaders, including nano-scale materials. Using mesoporous silica nanoparticles (MSNs) as a model nano-scale system, we show the interplay betw...

  • Article
  • Open Access
9 Citations
3,191 Views
16 Pages

The present study explored the impact of inhibiting α(1,6)fucosylation (core fucosylation) on the functional phenotype of a cellular model of colorectal cancer (CRC) malignization formed by the syngeneic SW480 and SW620 CRC lines. Expression of...

  • Article
  • Open Access
1,272 Views
13 Pages

KAT/3BP: A Metabolism-Targeting Agent with Single and Combination Activity in Aggressive B-Cell Lymphomas

  • Chiara Tarantelli,
  • Filippo Spriano,
  • Elisa Civanelli,
  • Luca Aresu,
  • Giorgia Risi,
  • Eleonora Cannas,
  • Omar Kayali,
  • Luciano Cascione,
  • Alberto J. Arribas and
  • Francesco Bertoni
  • + 1 author

18 June 2025

Background/Objectives: Reprogramming of the cellular metabolism is a hallmark of cancer, offering therapeutic opportunities to target cancer cell vulnerabilities for therapeutic purposes. 3-Bromopyruvate (3BP) is a small alkylating agent that functio...

  • Article
  • Open Access
11 Citations
4,225 Views
23 Pages

Heme Oxygenase-1 Has a Greater Effect on Melanoma Stem Cell Properties Than the Expression of Melanoma-Initiating Cell Markers

  • Anna Kusienicka,
  • Karolina Bukowska-Strakova,
  • Maciej Cieśla,
  • Witold Norbert Nowak,
  • Iwona Bronisz-Budzyńska,
  • Agnieszka Seretny,
  • Monika Żukowska,
  • Mateusz Jeż,
  • Rościsław Krutyhołowa and
  • Alicja Józkowicz
  • + 3 authors

Melanoma-initiating cells (MICs) contribute to the tumorigenicity and heterogeneity of melanoma. MICs are identified by surface and functional markers and have been shown to display cancer stem cell (CSC) properties. However, the existence of MICs th...

  • Article
  • Open Access
34 Citations
4,271 Views
14 Pages

Linoleic Acid Upregulates Microrna-494 to Induce Quiescence in Colorectal Cancer

  • Ruiko Ogata,
  • Shiori Mori,
  • Shingo Kishi,
  • Rika Sasaki,
  • Naoya Iwata,
  • Hitoshi Ohmori,
  • Takamitsu Sasaki,
  • Yukiko Nishiguchi,
  • Chie Nakashima and
  • Hiroki Kuniyasu
  • + 2 authors

25 December 2021

Cancer dormancy is a state characterized by the quiescence of disseminated cancer cells, and tumor recurrence occurs when such cells re-proliferate after a long incubation period. These cancer cells tend to be treatment resistant and one of the barri...

  • Article
  • Open Access
9 Citations
4,215 Views
24 Pages

The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response

  • Justine De Azevedo,
  • Jana Mourtada,
  • Cyril Bour,
  • Véronique Devignot,
  • Philippe Schultz,
  • Christian Borel,
  • Erwan Pencreach,
  • Georg Mellitzer,
  • Christian Gaiddon and
  • Alain C. Jung

14 September 2022

(1) Background: The first line of treatment for recurrent/metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) has recently evolved with the approval of immunotherapies that target the anti-PD-1 immune checkpoint. However, only about 20% of the p...

  • Article
  • Open Access
21 Citations
4,909 Views
17 Pages

Berberine Induces Combined Cell Death in Gastrointestinal Cell Lines

  • Shiori Mori,
  • Rina Fujiwara-Tani,
  • Momoko Gyoten,
  • Shota Nukaga,
  • Rika Sasaki,
  • Ayaka Ikemoto,
  • Ruiko Ogata,
  • Shingo Kishi,
  • Kiyomu Fujii and
  • Hiroki Kuniyasu

Berberine (BBR) is a plant alkaloid that has various biological activities. The effects of BBR on gastrointestinal cancer (GIC) have also been investigated and anti-tumor effects such as induction of cell death have been reported. However, the mechan...

  • Review
  • Open Access
22 Citations
4,260 Views
12 Pages

30 November 2022

As one of the leading causes of death from disease, cancer continues to pose a serious threat to human health globally. Despite the development of novel therapeutic regimens and drugs, the long-term survival of cancer patients is still very low, espe...

  • Article
  • Open Access
380 Views
12 Pages

DNA Damage Sensing and TP53 Function as Modulators of Sensitivity to Calicheamicin-Based Antibody–Drug Conjugates for Acute Leukemia

  • Camryn M. Pettenger-Willey,
  • George S. Laszlo,
  • Margery Gang,
  • Frances M. Cole,
  • Colin D. Godwin,
  • Sarah Erraiss,
  • Pritha Chanana,
  • Allie R. Kehret,
  • Junyang Li and
  • Roland B. Walter
  • + 2 authors

25 December 2025

Background/Objectives: Approved for treatment of acute leukemia, gemtuzumab ozogamicin (GO) and inotuzumab ozogamicin (InO) are antibody–drug conjugates (ADCs) that deliver a toxic calicheamicin (CLM) derivative. The resistance mechanisms to GO...

  • Article
  • Open Access
2 Citations
3,207 Views
17 Pages

Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth

  • Martin R. Ramos-Gonzalez,
  • Mohammad Tarique,
  • Lalit Batra,
  • Feyza Arguc,
  • Rodolfo Garza-Morales,
  • Haval Shirwan,
  • Esma S. Yolcu and
  • Jorge G. Gomez-Gutierrez

21 March 2024

Natural 4-1BBL (CD137L) is a cell membrane-bound protein critical to the expansion, effector function, and survival of CD8+ T cells. We reported the generation of an active soluble oligomeric construct, SA-4-1BBL, with demonstrated immunoprevention a...

  • Article
  • Open Access
6 Citations
3,793 Views
17 Pages

Down-Regulation of AKT Proteins Slows the Growth of Mutant-KRAS Pancreatic Tumors

  • Chuankai Chen,
  • Ya-Ping Jiang,
  • Inchul You,
  • Nathanael S. Gray and
  • Richard Z. Lin

19 June 2024

Serine/threonine kinase AKT isoforms play a well-established role in cell metabolism and growth. Most pancreatic adenocarcinomas (PDACs) harbor activation mutations of KRAS, which activates the PI3K/AKT signaling pathway. However, AKT inhibitors are...

  • Article
  • Open Access
1,788 Views
16 Pages

Treatment-Induced Gene Expression Changes in Metastatic Renal Cell Carcinoma: Insights from a Syngeneic Mouse Model

  • Ko Okabe,
  • Toshiaki Tanaka,
  • Tetsuya Shindo,
  • Yuki Kyoda,
  • Sachiyo Nishida,
  • Kohei Hashimoto,
  • Ko Kobayashi and
  • Naoya Masumori

This study aimed to clarify the alterations in gene expression in metastatic renal cell carcinoma (mRCC) during disease progression and in response to treatment with immune checkpoint inhibitors using a syngeneic mouse mRCC model. RENCA cells were or...

  • Article
  • Open Access
16 Citations
4,798 Views
15 Pages

Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo

  • Jeannine Lacroix,
  • Zoltán Kis,
  • Rafael Josupeit,
  • Franziska Schlund,
  • Alexandra Stroh-Dege,
  • Monika Frank-Stöhr,
  • Barbara Leuchs,
  • Jörg R. Schlehofer,
  • Jean Rommelaere and
  • Christiane Dinsart

3 June 2018

About 70% of all Ewing sarcoma (EWS) patients are diagnosed under the age of 20 years. Over the last decades little progress has been made towards finding effective treatment approaches for primarily metastasized or refractory Ewing sarcoma in young...

  • Article
  • Open Access
12 Citations
2,610 Views
17 Pages

Co-Functionalization of Gold Nanoparticles with C7H2 and HuAL1 Peptides: Enhanced Antimicrobial and Antitumoral Activities

  • Daniela M. D. Formaggio,
  • Jéssica A. Magalhães,
  • Vitor M. Andrade,
  • Katia Conceição,
  • Juliana M. Anastácio,
  • Gabrielli S. Santiago,
  • Denise C. Arruda and
  • Dayane B. Tada

The functionalization of nanoparticles with therapeutic peptides has been pointed out as a promising strategy to improve the applications of these molecules in the field of health sciences. Peptides are highly bioactive but face several limitations s...

  • Article
  • Open Access
3 Citations
2,071 Views
16 Pages

18 October 2024

Pancreatic cancer is one of the deadliest cancers globally, with limited success from existing therapies, including chemotherapies and immunotherapies like checkpoint inhibitors for patients with advanced pancreatic ductal adenocarcinoma (PDAC). A pr...

  • Article
  • Open Access
29 Citations
6,431 Views
19 Pages

Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast Cancer

  • Elena Mariotto,
  • Giampietro Viola,
  • Roberto Ronca,
  • Luca Persano,
  • Sanja Aveic,
  • Zaver M. Bhujwalla,
  • Noriko Mori,
  • Benedetta Accordi,
  • Valentina Serafin and
  • Roberta Bortolozzi

22 October 2018

Choline kinase (ChoK) is the first enzyme of the Kennedy pathway leading to the biosynthesis of phosphatidylcholine (PtdCho), the most abundant phospholipid in eukaryotic cell membranes. EB-3D is a novel choline kinase α1 (ChoKα1) inhibit...

  • Article
  • Open Access
11 Citations
9,948 Views
18 Pages

An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma

  • Emily K. Colvin,
  • Amanda L. Hudson,
  • Lyndsey L. Anderson,
  • Ramyashree Prasanna Kumar,
  • Iain S. McGregor,
  • Viive M. Howell and
  • Jonathon C. Arnold

5 August 2022

Mesothelioma is an aggressive cancer with limited treatment options and a poor prognosis. Phytocannabinoids possess anti-tumour and palliative properties in multiple cancers, however their effects in mesothelioma are unknown. We investigated the anti...

  • Article
  • Open Access
14 Citations
7,058 Views
18 Pages

TMEM176B Regulates AKT/mTOR Signaling and Tumor Growth in Triple-Negative Breast Cancer

  • Chifei Kang,
  • Ran Rostoker,
  • Sarit Ben-Shumel,
  • Rola Rashed,
  • James Andrew Duty,
  • Deniz Demircioglu,
  • Irini M. Antoniou,
  • Lika Isakov,
  • Zila Shen-Orr and
  • Emily Jane Gallagher
  • + 4 authors

6 December 2021

TMEM176B is a member of the membrane spanning 4-domains (MS4) family of transmembrane proteins, and a putative ion channel that is expressed in immune cells and certain cancers. We aimed to understand the role of TMEM176B in cancer cell signaling, ge...

  • Article
  • Open Access
8 Citations
3,414 Views
14 Pages

Investigation of Anti-Tumor Effects of an MLK1 Inhibitor in Prostate and Pancreatic Cancers

  • Yu-Ching Fan,
  • Kai-Cheng Hsu,
  • Tony-Eight Lin,
  • Dietmar Zechner,
  • Sung-Po Hsu and
  • Yuan-Chin Tsai

2 August 2021

It was shown that mixed lineage kinase 1 (MLK1) regulates pancreatic cancer growth; however, its role in prostate cancer remains unclear. We showed that MLK1 is a tumor marker in prostate cancer by analyzing clinical gene expression data and identifi...

  • Review
  • Open Access
18 Citations
9,329 Views
11 Pages

Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications

  • Ángela Bella,
  • Claudia Augusta Di Trani,
  • Myriam Fernández-Sendin,
  • Leire Arrizabalaga,
  • Assunta Cirella,
  • Álvaro Teijeira,
  • José Medina-Echeverz,
  • Ignacio Melero,
  • Pedro Berraondo and
  • Fernando Aranda

25 February 2021

Peritoneal carcinomatosis of primary tumors originating in gastrointestinal (e.g., colorectal cancer, gastric cancer) or gynecologic (e.g., ovarian cancer) malignancies is a widespread type of tumor dissemination in the peritoneal cavity for which fe...

  • Article
  • Open Access
19 Citations
6,038 Views
18 Pages

Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells

  • Jeannette Huaman,
  • Michelle Naidoo,
  • Xingxing Zang and
  • Olorunseun O. Ogunwobi

20 June 2019

Metastasis is the leading cause of cancer death worldwide. Circulating tumor cells (CTCs) are a critical step in the metastatic cascade and a good tool to study this process. We isolated CTCs from a syngeneic mouse model of hepatocellular carcinoma (...

  • Article
  • Open Access
10 Citations
4,122 Views
16 Pages

10 November 2021

Chemoattraction is a normal and essential process, but it can also be involved in tumorigenesis. This phenomenon plays a key role in glioblastoma (GBM). The GBM tumor cells are extremely difficult to eradicate, due to their strong capacity to migrate...

of 3